Genocea Biosciences, Inc. (NASDAQ: GNCA) Dead Cat bouncing

(24/7 Market News)  Echoing the classic “you can’t fire me, I quit” line, Genocea Biosciences, Inc. (NASDAQ: GNCA) formally notified The Nasdaq Stock Market that, in conjunction with its wind down of its operations, it is going to voluntarily delist its Common Stock from the Nasdaq Capital Market, as the Nasdaq Listing Qualifications department notified the Company that it was not in compliance with the Nasdaq Marketplace requirement, due to the Company’s common stock being below $1.00 for 30 consecutive business days.

After losing $0.1621 (-72.6906%) and closing at $0.0609, on 64,975,124 shares, yesterday, it’s trading at $0.11, up a nickel (+81.12%), on 26,635,168 shares, in this morning’s premarket.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.

RelatedNews

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist